Legis Daily

New Era of Preventing End-Stage Kidney Disease Act

USA118th CongressHR-6790| House 
| Updated: 12/17/2024
Gus M. Bilirakis

Gus M. Bilirakis

Republican Representative

Florida

Cosponsors (50)
Dwight Evans (Democratic)Stacey E. Plaskett (Democratic)Michael C. Burgess (Republican)Abigail Davis Spanberger (Democratic)Lisa Blunt Rochester (Democratic)Darren Soto (Democratic)Derek Kilmer (Democratic)Jefferson Van Drew (Republican)Neal P. Dunn (Republican)Patrick Ryan (Democratic)Lance Gooden (Republican)Sanford D. Bishop (Democratic)Glenn Thompson (Republican)Terri A. Sewell (Democratic)J. Luis Correa (Democratic)Scott H. Peters (Democratic)Paul Tonko (Democratic)Donald G. Davis (Democratic)Thomas R. Suozzi (Democratic)Andrew R. Garbarino (Republican)Danny K. Davis (Democratic)Ted Lieu (Democratic)Christopher H. Smith (Republican)Carol D. Miller (Republican)Mark DeSaulnier (Democratic)Daniel S. Goldman (Democratic)Dean Phillips (Democratic)Jerrold Nadler (Democratic)Kathy Castor (Democratic)Eleanor Holmes Norton (Democratic)Sam Graves (Republican)Julia Brownley (Democratic)Dan Crenshaw (Republican)Brian K. Fitzpatrick (Republican)Colin Z. Allred (Democratic)Jay Obernolte (Republican)Deborah K. Ross (Democratic)Mike Thompson (Democratic)Bill Posey (Republican)Yadira Caraveo (Democratic)Zoe Lofgren (Democratic)Michael Lawler (Republican)Bradley Scott Schneider (Democratic)Jack Bergman (Republican)Troy Balderson (Republican)Jennifer A. Kiggans (Republican)Bill Pascrell (Democratic)Susan Wild (Democratic)Mike Levin (Democratic)Judy Chu (Democratic)

Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
View Full Text
Timeline

Bill from Previous Congress

HR 117-7506
New Era of Preventing End-Stage Kidney Disease Act
Dec 14, 2023
Introduced in House
Dec 14, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Dec 15, 2023
Referred to the Subcommittee on Health.
Dec 17, 2024
Referred to the Subcommittee on Health.
  • Bill from Previous Congress

    HR 117-7506
    New Era of Preventing End-Stage Kidney Disease Act


  • December 14, 2023
    Introduced in House


  • December 14, 2023
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • December 15, 2023
    Referred to the Subcommittee on Health.


  • December 17, 2024
    Referred to the Subcommittee on Health.

Health

Congressional oversightDigestive and metabolic diseasesGeneticsGovernment studies and investigationsHealth care coverage and accessHealth programs administration and fundingHealth promotion and preventive careMedical educationMedical researchMedical tests and diagnostic methodsResearch administration and funding

New Era of Preventing End-Stage Kidney Disease Act

USA118th CongressHR-6790| House 
| Updated: 12/17/2024
View Full Text
Timeline

Bill from Previous Congress

HR 117-7506
New Era of Preventing End-Stage Kidney Disease Act
Dec 14, 2023
Introduced in House
Dec 14, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Dec 15, 2023
Referred to the Subcommittee on Health.
Dec 17, 2024
Referred to the Subcommittee on Health.
  • Bill from Previous Congress

    HR 117-7506
    New Era of Preventing End-Stage Kidney Disease Act


  • December 14, 2023
    Introduced in House


  • December 14, 2023
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • December 15, 2023
    Referred to the Subcommittee on Health.


  • December 17, 2024
    Referred to the Subcommittee on Health.
Gus M. Bilirakis

Gus M. Bilirakis

Republican Representative

Florida

Cosponsors (50)
Dwight Evans (Democratic)Stacey E. Plaskett (Democratic)Michael C. Burgess (Republican)Abigail Davis Spanberger (Democratic)Lisa Blunt Rochester (Democratic)Darren Soto (Democratic)Derek Kilmer (Democratic)Jefferson Van Drew (Republican)Neal P. Dunn (Republican)Patrick Ryan (Democratic)Lance Gooden (Republican)Sanford D. Bishop (Democratic)Glenn Thompson (Republican)Terri A. Sewell (Democratic)J. Luis Correa (Democratic)Scott H. Peters (Democratic)Paul Tonko (Democratic)Donald G. Davis (Democratic)Thomas R. Suozzi (Democratic)Andrew R. Garbarino (Republican)Danny K. Davis (Democratic)Ted Lieu (Democratic)Christopher H. Smith (Republican)Carol D. Miller (Republican)Mark DeSaulnier (Democratic)Daniel S. Goldman (Democratic)Dean Phillips (Democratic)Jerrold Nadler (Democratic)Kathy Castor (Democratic)Eleanor Holmes Norton (Democratic)Sam Graves (Republican)Julia Brownley (Democratic)Dan Crenshaw (Republican)Brian K. Fitzpatrick (Republican)Colin Z. Allred (Democratic)Jay Obernolte (Republican)Deborah K. Ross (Democratic)Mike Thompson (Democratic)Bill Posey (Republican)Yadira Caraveo (Democratic)Zoe Lofgren (Democratic)Michael Lawler (Republican)Bradley Scott Schneider (Democratic)Jack Bergman (Republican)Troy Balderson (Republican)Jennifer A. Kiggans (Republican)Bill Pascrell (Democratic)Susan Wild (Democratic)Mike Levin (Democratic)Judy Chu (Democratic)

Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Congressional oversightDigestive and metabolic diseasesGeneticsGovernment studies and investigationsHealth care coverage and accessHealth programs administration and fundingHealth promotion and preventive careMedical educationMedical researchMedical tests and diagnostic methodsResearch administration and funding